Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 501–525 of 566 matching trials (filtered from 7,816) · page 21 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) NCT01353430 Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | University of California, Irvine OTHER |
2025-06-18 |
|
Gut Microbiomes in HD NCT06448546 Runs in: United States · 1 site |
NA other |
RECRUITING | 36 | University of Central Florida OTHER |
2025-06-18 |
|
Time Restricted Eating in Alzheimer's Disease NCT06429124 Dietary Intervention Runs in: United States · 2 sites |
NA other |
RECRUITING | 30 | St. Joseph's Hospital and Medical Center, Phoenix OTHER |
2025-06-06 |
|
Demonstrating the Efficacy of a Spanish-Language Program for Latino Dementia Caregivers NCT06747637 Skill-building classes; Wait list control group Runs in: United States · 1 site |
NA other |
RECRUITING | 225 | University of Southern California OTHER |
2025-06-06 |
|
Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes NCT07005895 Hydration assessment via mobile app Runs in: United States · 1 site |
NA other |
RECRUITING | 200 | PepsiCo Global R&D INDUSTRY |
2025-06-05 |
|
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease NCT05968703 Combined STN+NBM DBS Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | Helen M. Bronte-Stewart OTHER |
2025-05-30 |
|
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168 Runs in: Australia; United States · 2 sites |
NA other |
RECRUITING | 20,000 | Sanford Health OTHER |
2025-05-29 |
|
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia NCT06644573 PROSOMNIA Sleep Therapy™ (PSTx); Anesthesia-Induced Sleep Therapy; ... Runs in: United States · 1 site |
PHASE1 other |
NOT_YET_RECRUITING | 100 | Nyree Penn INDUSTRY |
2025-05-28 |
|
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease NCT04800588 California Cognitive Assessment Battery Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Neurobehavioral Systems, Inc. INDUSTRY |
2025-05-22 |
|
A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects NCT06964230 T3D-959; Placebo Comparator Runs in: United States · 1 site |
PHASE2|PHASE3 other |
NOT_YET_RECRUITING | 376 | T3D Therapeutics, Inc. INDUSTRY |
2025-05-09 |
|
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks NCT06089161 Standard of Care; Personalized OSA Treatment Runs in: United States · 1 site |
NA other |
RECRUITING | 330 | University of Miami OTHER |
2025-05-08 |
|
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia NCT06613971 Runs in: United States · 1 site |
NA other |
RECRUITING | 50 | MD Stem Cells INDUSTRY |
2025-05-08 |
|
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624 18F-OP-801 Runs in: United States · 3 sites |
PHASE1|PHASE2 other |
RECRUITING | 65 | Ashvattha Therapeutics, Inc. INDUSTRY |
2025-05-02 |
|
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation NCT06945614 Xenon gas inhalation Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 16 | General Biophysics LLC INDUSTRY |
2025-04-25 |
|
Huntington's Disease Biobank: Advancing Remote Monitoring and Deep Phenotyping NCT06941662 computer vision, remote monitoring, blood, urine, wrist bands, mobile-app Runs in: United States · 1 site |
NA other |
RECRUITING | 200 | Stanford University OTHER |
2025-04-24 |
|
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia NCT05374278 [18F]RP-115 PET/MRI or PET/CT and MRI Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 102 | David Wilson OTHER |
2025-04-17 |
|
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment NCT05591027 Centella asiatica product; Placebo Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 48 | Oregon Health and Science University OTHER |
2025-04-11 |
|
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease NCT05667649 RB-ADSC Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 18 | Regeneration Biomedical, Inc. INDUSTRY |
2025-04-04 |
|
Sleep-dependent Learning in Aging NCT03840083 Sleep Runs in: United States · 1 site |
NA other |
RECRUITING | 584 | University of Massachusetts, Amherst OTHER |
2025-04-03 |
|
Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department NCT06326424 Empatica EmbracePlus Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Ohio State University OTHER |
2025-04-03 |
|
Strengthening Health and Insight in New Educators NCT06745934 Healthy Minds Program Runs in: United States · 1 site |
NA other |
RECRUITING | 140 | University of Alabama, Tuscaloosa OTHER |
2025-04-02 |
|
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease NCT03019757 DaTscan; F18-AV-45; FDG-PET; APOE genotype; Polysomnogram; Clinical... Runs in: United States · 1 site |
NA other |
RECRUITING | 76 | Douglas Scharre OTHER |
2025-03-30 |
|
Pimavanserin and Aggression and Social Cognition. NCT05895513 Pimavanserin 34 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 35 | Ohio State University OTHER |
2025-03-27 |
|
ALS Research Collaborative NCT06885918 Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | ALS Therapy Development Institute OTHER |
2025-03-20 |
|
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) NCT04956549 Physical activity program; Successful Aging Runs in: United States · 1 site |
NA other |
RECRUITING | 144 | Pennington Biomedical Research Center OTHER |
2025-03-17 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial